Paragon Care formalises leadership transition as CEO Carmen Riley becomes Managing Director

The latest announcement is out from Paragon Care Limited ( (AU:PGC) ).

Paragon Care has elevated Chief Executive Officer Carmen Riley to the dual role of CEO and Managing Director from 1 March 2026, formalising the next step in a succession plan first outlined in mid-2025. Riley, who has more than 15 years’ experience across Paragon Care and Clifford Hallam Healthcare, is credited with driving operational improvements, integration progress and strategic strengthening as the company prepares for its next growth phase.

Outgoing Managing Director David Collins will move to the role of Executive Director, where he will continue to focus on corporate development, M&A opportunities and completion of key integration initiatives. The leadership reshuffle, backed by the board, is designed to maintain continuity while positioning Paragon Care to accelerate growth in its healthcare markets, underpinned by a detailed employment package for Riley that includes fixed and incentive-based remuneration and defined notice and restraint terms.

The most recent analyst rating on (AU:PGC) stock is a Hold with a A$0.19 price target. To see the full list of analyst forecasts on Paragon Care Limited stock, see the AU:PGC Stock Forecast page.

More about Paragon Care Limited

Paragon Care Limited is an Australia-based listed healthcare company that operates as a wholesaler, distributor and manufacturer across the Asia-Pacific region. The group supplies medical equipment, devices, consumables, pharmaceuticals, complementary medicines, nutritional products and blood bank diagnostic reagents to healthcare markets in Australia, New Zealand and Asia.

Average Trading Volume: 1,116,734

Technical Sentiment Signal: Sell

Current Market Cap: A$339.3M

For detailed information about PGC stock, go to TipRanks’ Stock Analysis page.